Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial
Open Access
- 30 September 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 7 (11), 941-950
- https://doi.org/10.1016/s2213-2600(19)30199-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09Clinical Infectious Diseases, 2012
- Design and Performance of the CDC Real-Time Reverse Transcriptase PCR Swine Flu Panel for Detection of 2009 A (H1N1) Pandemic Influenza VirusJournal of Clinical Microbiology, 2011
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Outcomes of adults hospitalised with severe influenzaThorax, 2010
- Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with InfluenzaThe Journal of Infectious Diseases, 2009
- The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*Critical Care Medicine, 2009
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- The pediatric early warning system score: A severity of illness score to predict urgent medical need in hospitalized childrenJournal of Critical Care, 2006
- Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre studyThe Lancet, 2003
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972